1981
DOI: 10.1159/000250167
|View full text |Cite
|
Sign up to set email alerts
|

Erythropoietic Protoporphyria in Slovenia

Abstract: 32 patients with EPP were detected in Slovenia, which gives an incidence of 1.71 cases/100,000 inhabitants. 20 patients had typical clinical symptoms and increased values of laboratory assays, 12 patients had either slightly expressed clinical symptoms or increased values of laboratory tests; these patients were diagnosed as latent cases. The patients belong to 12 families, no blood relationship between these families could be established. In 7 families the latent carriers of this inborn error of the porphyrin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 1 publication
0
3
0
Order By: Relevance
“…Erythropoietic protoporphyria may display similar skin symptoms, but not oral lesions. 5 Increased values of protoporphyrin in erythrocytes are a key symptom.…”
Section: Discussionmentioning
confidence: 99%
“…Erythropoietic protoporphyria may display similar skin symptoms, but not oral lesions. 5 Increased values of protoporphyrin in erythrocytes are a key symptom.…”
Section: Discussionmentioning
confidence: 99%
“…PCT is an acquired disease although in some individuals a genetic deficiency of the enzyme uroporphyrinogen decarboxylase contributes to the disease severity and development (Sassa and Kappa, 2000; American Porphyria Foundation, 2005). The main porphyrin precursor that accumulates in the human porphyria type EPP is protoporphyrin (Kansky and Glavaè, 2004). In EPP patients a markedly decreased activity of the enzyme ferrochelatase is found (Sarkani and Cox, 1995; Straka et al, 1991).…”
Section: Discussionmentioning
confidence: 99%
“…More recent studies indicate that patients with liver complications share a common genetic feature (“null allele mutation”) that results in the formation of a truncated protein (Kansky and Glavac, 1994). The striking difference between the dog and man might be due to the fact that impairment of ferrochelatase activity occurs by a different mechanism, i.e.…”
Section: Discussionmentioning
confidence: 99%